JC 220 - Fully Automated CLIA Analyzers
TEST MENU
Benefits
Optimized Operational Efficiency
The integration of "True Whole Blood" technology simplifies sample processing, allowing clinical laboratories to streamline daily workflows.
Comprehensive Clinical Insight
The system empowers healthcare providers with broad diagnostic capabilities, covering critical disease areas including Cardiovascular Disease (CVD), Alzheimer's Disease (AD), and Tumors.
Proactive Disease Management
The platform supports early screening and continuous disease monitoring, enabling clinicians to confidently evaluate conditions such as cognitive impairment and myocardial injury.
Versatile Diagnostic Application
It functions as a consolidated solution for diverse testing requirements, allowing laboratories to efficiently process panels ranging from coagulation function to reproductive health and glycometabolism.
Features
| Feature | Technical Details |
| Methodology | Direct Chemiluminescence Immunoassay (Acridinium Ester) |
| Throughput | 220 T/h |
| Time to First Result | 9 minutes |
| Reagent Positions | 18 |
| Sample Positions | 125 positions; supports continuous loading and STAT (emergency) prioritization |
| Onboard Refrigeration | 2–8°C, 24-hour continuous cooling |
| Sample Types | Serum, plasma, urine, cerebrospinal fluid (CSF), etc. |
| Data Storage | 8GB |
| Size | 1170mm×700mm×740mm |